Sanofi SA banner

Wall St Price Targets

SNYNF Price Targets Summary
Sanofi SA

Wall Street analysts forecast SNYNF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNYNF is 109.39 USD with a low forecast of 64.78 USD and a high forecast of 132.32 USD.

Lowest Forecast
Price Target
64.78 USD
22% Downside
Average Forecast
Price Target
109.39 USD
31% Upside
Highest Forecast
Price Target
132.32 USD
59% Upside
Sanofi SA Competitors:
Price Targets

Revenue
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.

Gross Profit
Forecast

2% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.

Operating Income
Forecast

2% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 14%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
34% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
34% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 34%.

Net Income
Forecast

4% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
4% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SNYNF's stock price target?
Price Target
109.39 USD

According to Wall Street analysts, the average 1-year price target for SNYNF is 109.39 USD with a low forecast of 64.78 USD and a high forecast of 132.32 USD.

What is the Revenue forecast for Sanofi SA?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for Sanofi SA?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.

What is the Operating Income forecast for Sanofi SA?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 14%.

What is the Pre-Tax Income forecast for Sanofi SA?
Projected CAGR
34%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 34%.

What is the Net Income forecast for Sanofi SA?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett